Citation map · Study

Different initiatives across Europe to enhance losartan utilization post generics: impact and implications

16 references·0 citing·37 second hop

this work references cited by second hop

References

2011The ‘Wise List’– A Comprehensive Concept to Select, Communicate and Achieve Adherence to Recommendations of Essential Drugs in Ambulatory Care in Stockholm224 cited
2010Comparing policies to enhance prescribing efficiency in Europe through increasing generic utilization: changes seen and global implications153 cited
2009Multifaceted national and regional drug reforms and initiatives in ambulatory care in Sweden: global relevance150 cited
2007The Ongoing Regulation of Generic Drugs135 cited
2014Multiple policies to enhance prescribing efficiency for established medicines in Europe with a particular focus on demand-side measures: findings and future implications129 cited
2012The impact of pharmaceutical pricing and reimbursement policies on generics uptake: implementation of policy options on generics in 29 European countries─an overview115 cited
2011Policies to Enhance Prescribing Efficiency in Europe: Findings and Future Implications113 cited
2004What are the obstacles to generic substitution? An assessment of the behaviour of prescribers, patients and pharmacies during the first year of generic substitution in Sweden106 cited
2009Soft regulations in pharmaceutical policy making97 cited
2013Reforms and initiatives in Scotland in recent years to encourage the prescribing of generic drugs, their influence and implications for other countries86 cited
2011Influence of demand-side measures to enhance renin–angiotensin prescribing efficiency in Europe: implications for the future82 cited
2012Multiple initiatives continue to enhance the prescribing efficiency for the proton pump inhibitors and statins in Scotland

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

Cited by

No citing works inside the corpus for this window.